Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease

Venetoclax is a promising new drug for relapsed or refractory chronic lymphocytic leukemia (CLL). However, venetoclax use had not been reported in severe chronic kidney disease (CKD) patients. We report the first case of relapsed CLL in a severe CKD patient that was successfully treated with venetoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiura, Hiroyuki, Sezaki, Nobuo, Ishikawa, Tatsunori, Kuroi, Taiga, Okamoto, Sachiyo, Nomura, Naho, Masunari, Taro, Nakasako, Yukio, Kiguchi, Toru, Tanimoto, Mitsune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010727/
https://www.ncbi.nlm.nih.gov/pubmed/35441018
http://dx.doi.org/10.1002/ccr3.5735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010727/
https://www.ncbi.nlm.nih.gov/pubmed/35441018
http://dx.doi.org/10.1002/ccr3.5735

Ejemplares similares